Cargando…

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing

Circulating tumor DNA (ctDNA) is released from cancer cells and oncogenic mutations in ctDNA can be measured from plasma samples. Droplet digital PCR (ddPCR) is a sensitive and specific method for the detection of mutations in ctDNA. We analyzed serial plasma samples (n = 80) from ten metastatic col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holm, Matilda, Andersson, Emma, Osterlund, Emerik, Ovissi, Ali, Soveri, Leena-Maija, Anttonen, Anna-Kaisa, Kytölä, Soili, Aittomäki, Kristiina, Osterlund, Pia, Ristimäki, Ari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688175/ https://www.ncbi.nlm.nih.gov/pubmed/33237900 http://dx.doi.org/10.1371/journal.pone.0239819

Ejemplares similares

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
por: Osterlund, Emerik, et al.
Publicado: (2022)

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study
por: Uutela, Aki, et al.
Publicado: (2022)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

Diagnostic performance of Idylla MSI test in colorectal cancer biopsies
por: Ukkola, Iiris, et al.
Publicado: (2023)

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study
por: Osterlund, Pia, et al.
Publicado: (2021)

Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer
por: SOVERI, LEENA-MAIJA, et al.
Publicado: (2014)

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
por: Ukkola, Iiris, et al.
Publicado: (2023)

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
por: Lehtomäki, Kaisa, et al.
Publicado: (2022)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome
por: Illman, Johanna, et al.
Publicado: (2022)

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
por: Vivancos, Ana, et al.
Publicado: (2019)

Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy
por: Ålgars, Annika, et al.
Publicado: (2014)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
por: Offerman, Saskia, et al.
Publicado: (2021)

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers
por: Ukkola, Iiris, et al.
Publicado: (2022)

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
por: Ljunggren, Malin, et al.
Publicado: (2022)

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
por: Österlund, P, et al.
Publicado: (2011)

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
por: Vessies, D. C. L., et al.
Publicado: (2020)

Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial – Authors’ reply
por: Osterlund, Pia, et al.
Publicado: (2021)

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla(™) KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer
por: Solassol, Jérôme, et al.
Publicado: (2016)

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and (1)H-MR spectroscopy compared with histology (subgroup in the RAXO trial)
por: Uutela, A., et al.
Publicado: (2021)

Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer
por: Tolonen, Antti, et al.
Publicado: (2023)

Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics
por: Holm, Matilda, et al.
Publicado: (2018)

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
por: Caputo, Alessandro, et al.
Publicado: (2021)

Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR
por: Léonce, Camille, et al.
Publicado: (2023)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

GLIM in diagnosing malnutrition and predicting outcome in ambulatory patients with head and neck cancer
por: Orell, Helena Kristiina, et al.
Publicado: (2022)

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study
por: Isoniemi, H, et al.
Publicado: (2021)

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
por: Holm, Matilda, et al.
Publicado: (2020)

N-glycomic profiling of colorectal cancer according to tumor stage and location
por: Holm, Matilda, et al.
Publicado: (2020)

Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome
por: Holm, Matilda, et al.
Publicado: (2019)

A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
por: Osterlund, Pia, et al.
Publicado: (2014)

Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
por: Eigeliene, Natalja, et al.
Publicado: (2021)

Fully automated diagnosis of MERS-CoV infection in respiratory specimen on the IdyllaTM MDx Platform
por: Trost, N., et al.
Publicado: (2016)

Performance of Idylla(™) RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer
por: Makutani, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2k9liaed8mc6dsguc6f5nj7k8